Technical Analysis for ACST - Acasti Pharma, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Down | Flat |
Date | Alert Name | Type | % Chg |
---|---|---|---|
MACD Bullish Signal Line Cross | Bullish | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
20 DMA Resistance | Bearish | 1.76% | |
MACD Bearish Signal Line Cross | Bearish | 1.76% | |
Outside Day | Range Expansion | 1.76% | |
Wide Bands | Range Expansion | 1.76% | |
Down 3 Days in a Row | Weakness | 1.76% | |
MACD Bullish Signal Line Cross | Bullish | -2.03% | |
NR7 | Range Contraction | -2.03% | |
Inside Day | Range Contraction | -2.03% |
Alert | Time |
---|---|
Down 2 % | about 17 hours ago |
Down 1% | about 17 hours ago |
Possible NR7 | about 18 hours ago |
Possible Inside Day | about 18 hours ago |
Rose Above 10 DMA | about 19 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 06/21/2024
Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of new therapies for abnormalities in blood lipids, and the treatment and prevention of cardiovascular disorders. The company offers Onemia, a medical food that is used in the dietary management of illnesses associated with omega-3 phospholipids deficiency related to cardiometabolic disorders. Its product development pipeline includes CaPre, a drug product candidate that is in Phase II clinical trial for the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia. The company was incorporated in 2002 and is headquartered in Laval, Canada. Acasti Pharma Inc. is a subsidiary of Neptune Technologies & Bioressources Inc.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cardiovascular Disease Lipid Drug Products Metabolic Disorders Fatty Acids Triglyceride Hypertriglyceridemia Medical Food Onemia
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cardiovascular Disease Lipid Drug Products Metabolic Disorders Fatty Acids Triglyceride Hypertriglyceridemia Medical Food Onemia
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 3.834 |
52 Week Low | 1.72 |
Average Volume | 23,525 |
200-Day Moving Average | 2.62 |
50-Day Moving Average | 3.24 |
20-Day Moving Average | 3.00 |
10-Day Moving Average | 2.88 |
Average True Range | 0.18 |
RSI (14) | 41.18 |
ADX | 23.15 |
+DI | 22.54 |
-DI | 17.25 |
Chandelier Exit (Long, 3 ATRs) | 2.87 |
Chandelier Exit (Short, 3 ATRs) | 3.20 |
Upper Bollinger Bands | 3.43 |
Lower Bollinger Band | 2.58 |
Percent B (%b) | 0.37 |
BandWidth | 28.43 |
MACD Line | -0.10 |
MACD Signal Line | -0.11 |
MACD Histogram | 0.003 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 3.11 | ||||
Resistance 3 (R3) | 3.10 | 3.00 | 3.08 | ||
Resistance 2 (R2) | 3.00 | 2.95 | 3.01 | 3.06 | |
Resistance 1 (R1) | 2.95 | 2.91 | 2.97 | 2.96 | 3.05 |
Pivot Point | 2.85 | 2.85 | 2.87 | 2.86 | 2.85 |
Support 1 (S1) | 2.80 | 2.80 | 2.83 | 2.82 | 2.73 |
Support 2 (S2) | 2.70 | 2.76 | 2.71 | 2.72 | |
Support 3 (S3) | 2.65 | 2.70 | 2.70 | ||
Support 4 (S4) | 2.67 |